UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000007483 |
|---|---|
| Receipt number | R000008826 |
| Scientific Title | Etiological analysis of chronic cough |
| Date of disclosure of the study information | 2012/03/10 |
| Last modified on | 2012/03/12 08:59:22 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Etiological analysis of chronic cough
Acronym
Etiology of chronic cough
Scientific Title
Etiological analysis of chronic cough
Scientific Title:Acronym
Etiology of chronic cough
Region
| Japan |
Condition
Condition
Chronic cough
Classification by specialty
| Pneumology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To elucidate the causes of chronic cough by the systematic treating cascade
Basic objectives2
Others
Basic objectives -Others
To analyse the beta-agonist responsive cough
Trial characteristics_1
Exploratory
Trial characteristics_2
Explanatory
Developmental phase
Not applicable
Assessment
Primary outcomes
To clarify the etiology of chronic cough
Key secondary outcomes
To categorize beta-agonist responsive cough
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 78 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Consecutively resister patients who visit cough clinic
Key exclusion criteria
Patients who can not finish the protocol
Target sample size
184
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Mitsusi Okazawa |
Organization
Fujita Health University
Division name
Respiratory medicine and clinical allergy
Zip code
Address
1-98 Dengakugakubo Kutsukakecho Toyoake
TEL
0562-93-9003
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Mitsushi Okazawa |
Organization
Fujita Health University
Division name
Respiratory medicine and clinical allergy
Zip code
Address
1-98 Dengakugakubo Kutsukakecho Toyoake
TEL
0562-93-9003
Homepage URL
mokazawa@fujita-hu.ac.jp
Sponsor or person
Institute
Respiratory medicine and clinical allergy
Institute
Department
Personal name
Funding Source
Organization
Fujita Health University
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2012 | Year | 03 | Month | 10 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2004 | Year | 04 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2004 | Year | 04 | Month | 01 | Day |
Last follow-up date
| 2007 | Year | 12 | Month | 01 | Day |
Date of closure to data entry
| 2007 | Year | 12 | Month | 01 | Day |
Date trial data considered complete
| 2007 | Year | 12 | Month | 01 | Day |
Date analysis concluded
| 2008 | Year | 12 | Month | 01 | Day |
Other
Other related information
To clarify the etiology of chronic cough, Procaterol inhalation, oral administration of Clarithromycin plus Carbocysteine, Cetirizine and Rabeprazole were systematically administered.
Management information
Registered date
| 2012 | Year | 03 | Month | 10 | Day |
Last modified on
| 2012 | Year | 03 | Month | 12 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008826
